Previous close | 0.0800 |
Open | 0.0800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0800 - 0.0800 |
52-week range | 0.0800 - 0.0800 |
Volume | |
Avg. volume | 0 |
Market cap | 199.95M |
Beta (5Y monthly) | 1.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 16 Feb 2024 |
1y target est | N/A |
BORDEAUX, France & BOSTON, April 25, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, informs its shareholders that its Ordinary General Meeting was held on Thursday April 25, 2024, at 2:00 pm CEST at the Company's registered office, in Martillac.
BORDEAUX, France & BOSTON, April 09, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, today announces its revenue for the first quarter of 2024.
BORDEAUX, France & BOSTON, March 06, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, today announced its 2023 full-year results, as of December 31, 2023, as approved by the Board of Directors on March 5, 2024.